Progressive Management
Progressive Management - Related Videos
02:07
Tumor Progression
0 Views •
2023
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages. Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07
Tumor Progression
0 Views •
2021
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages. Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:34
Early Intervention and Pain Management
0 Views •
2026
All animal procedures described here must be conducted in accordance with institutional animal ethics guidelines and approved by IACUC. All procedures must follow the principles of the 3Rs—Replacement, Reduction, and Refinement—and must be performed by trained personnel. Monitoring Animals for Signs of Pain and Distress Recognizing early signs of pain is essential for ethical animal research. Animals are routinely monitored using behavioral, physical, and physiological parameters that reflect...
09:25
Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
0 Views •
Cited by 34 •
2013
Improved understanding of pancreatic cancer biology is critically needed to enable the development of better therapeutic options to treat pancreatic cancer. To address this need, we demonstrate an orthotopic model of pancreatic cancer that permits non-invasive monitoring of cancer progression using in vivo bioluminescence imaging.
01:33
Breeding Management in Rodent Studies
0 Views •
2026
All animal procedures described here must be conducted in accordance with institutional animal ethics guidelines and approved by IACUC. All procedures must follow the principles of the 3Rs—Replacement, Reduction, and Refinement—and must be performed by trained personnel. Breeding management supports the 3Rs by minimizing unnecessary animal production and ensuring that only the number of animals required for a study is generated. Effective breeding strategies help reduce surplus animals and...
FAQs
It operates through linked decision points rather than a single treatment choice. Clinicians interpret the patient’s current symptoms, functional status, risks, and previous treatment response, then select an intervention with a defined goal. At reassessment, the observed trajectory determines whether care should intensify, change, continue, or decrease. This keeps treatment responsive to evidence gathered during care.
Defined goals make reassessment more than a routine check. They provide a reference for judging whether symptoms or function have improved, remained unchanged, or worsened, while risk review adds context to the decision. If goals are not met, the next step can be reconsidered; if outcomes improve, reducing treatment may help avoid unnecessary intervention.
The approach links escalation to evidence that current care is insufficient, rather than treating intensification as automatic. Persistent symptoms, limited functional improvement, or changing risks can support a stronger or different intervention. Conversely, improvement can support decreasing treatment. This balance helps clinicians respond to unmet needs without continuing or adding care that is no longer necessary.
A practical workflow begins with assessment of symptoms, functional status, risks, and the response to treatment. Clinicians then establish a goal, choose an intervention, and identify when outcomes will be reviewed. At follow-up, they compare the patient’s current status with the intended outcome and decide whether to continue, modify, intensify, or reduce care.
Escalation or modification becomes relevant when conservative measures do not produce the intended improvement, when symptoms persist, or when functional status fails to progress toward the defined goal. A change in risk can also alter the plan. The decision follows reassessment, allowing the clinician to match the next intervention to the patient’s current needs.
Progressive management gives follow-up a clear purpose by connecting each review with treatment goals, current findings, and the patient’s clinical trajectory. Documenting how symptoms, function, risks, and outcomes change can help coordinate decisions over time. It also supports individualized care because subsequent steps reflect the patient’s response rather than relying solely on the initial plan.